WASHINGTON — Immunomedics, Inc. , a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious …
Visit link:
Lupus Patients Treated With Epratuzumab Report Improvements in Health-Related Quality of Life




